scholarly journals Social support, quality of life and mental health status in breast cancer patients

2017 ◽  
Vol 1 (2) ◽  
Author(s):  
Jenesh Singh Shrestha ◽  
Alish Shrestha ◽  
Abja Sapkota ◽  
Rakshya Sharma ◽  
Samip Shrestha ◽  
...  
2020 ◽  
Vol 26 (6) ◽  
pp. 1421-1428
Author(s):  
Ebrahim Salehifar ◽  
Ghasem Janbabaei ◽  
Abbas Alipour ◽  
Nasim Tabrizi ◽  
Razieh Avan

Purpose Taxane-induced peripheral neuropathy (TIPN) is a common and bothersome toxicity. This study aimed to determine the incidence and severity of TIPN in patients with breast cancer and to investigate the relationship between TIPN and quality of life. Methods A total of 82 breast cancer patients with TIPN symptoms were included in this study. The criteria of National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE v4.03) and the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30, version 3.0) were used to evaluate grading of sensory neuropathy and quality of life, respectively. Analysis of the data was done by IBM SPSS statistics version 23. Results A total of 346 patients received taxane-based chemotherapy and 82 patients (23.7%) experience TIPN. The mean (SD) global health status/quality of life, physical functioning, role functioning, and pain subscales were 60.63 (5.26), 80.64 (9.05), 81.77 (10.41), and 43.88 (11.27), respectively. There were significant negative correlations between global health status/quality of life, physical functioning, and role functioning subscales with the grade of neuropathy (r = −0.33, −0.80, and −0.61, respectively) and positive correlation between pain subscale and the grade of neuropathy (r = 0.70). Conclusion This study shows a clear association between TIPN and worsened quality of life. These findings emphasize on detecting and management of TIPN in an effort to improve the quality of life of breast cancer patients.


2011 ◽  
Vol 108 (3) ◽  
pp. 923-942 ◽  
Author(s):  
Florence Cousson-Géalie ◽  
Marilou Bruchon-Schweitzer ◽  
Thierry Atzeni ◽  
Nadine Houede

The purpose of this research was to demonstrate that a specific psychosocial intervention changes reactions to cancer and quality of life. This study was carried out on 66 patients with a first breast cancer. Patients were randomly divided into two groups: a specific intervention group (G1, 8 sessions) or a support group (G2, 8 sessions). A control group (G3) was composed of patients who refused to participate in psychological intervention. Social support, perceived control, repression of emotions, coping strategies, emotional distress, and quality of life were assessed one week before (T1) and at the end (T2) of the psychological intervention. Results showed that G1 did not have significantly modified quality of life or psychological scores. Patients of G2 had poorer emotional quality of life, use of internal causal attributions, and minimized their illness at T1 as compared to patients of G3. At Time 2 these differences were not observed.


2020 ◽  
Author(s):  
Rahel Aberaraw ◽  
Jemal Hussien ◽  
Abdisa Boka ◽  
Roza Teshome ◽  
Addisu Yeshambel

Abstract Background Breast cancer is a major life-threatening public health problem worlwide. It is the most common form of cancer among women in many developing countries including Ethiopia. Social support could change the course of cancer and can influence the quality of life among breast cancer patients. Therefore, purpose of this study was to assess social support and quality of life among female breast cancer patients attending in Tikur Anbassa Specialized Hospital, Addis Ababa, Ethiopia 2019.Methods A Hospital-based cross-sectional study was conducted in Tikur Anbessa Specialized Hospital, Ethiopia from March to April 2019. A total of 214 female breast cancer patients were included and a systematic sampling method was used. A structured and pre-tested questionnaire was used. Data entry was done using epi data manager version 4.2. Data analysis was done using Statistical Package for Social Sciences version 25. Binary and multiple logistic regression was used to show the association of social support and quality of life. Variables significantly associated were declared at P-value <0.05 and 95%CI was used.Result A total of 214 women with breast cancer were recruited. Of the total participants, 124(58%) had good social support. It was found that participants who were college graduated (AOR=3, 95%CI: 1.5, 5.9 COR=3.2) and who had high monthly income(AOR=2.3, 95% CI: 1.2,8.5, COR= 5.39) were more likely to have good social support. It was also found that participants who were illiterate (AOR=3, 95%CI: 1.3,6.9, COR=4.8, p-value=0.008), who had systematic therapy side effects(AOR=3.8, 95%CI: 1.1,13, COR=4, p-value=0.035)and participants who had problem of appetite loss(AOR=3.5, 95%CI: 1.02,12COR=4, p-value= 0.047) were more likely to have affected QoL. Conclusion In this study finding, social support and, quality of life in breast cancer patients was low. Healthcare providers should enhance social support which may help to improve the quality of life of women with breast cancer.


2016 ◽  
Vol 33 (S1) ◽  
pp. S419-S419
Author(s):  
C.G. Ng ◽  
S. Mohamed ◽  
M.H. See ◽  
F. Harun ◽  
A.H. Sulaiman ◽  
...  

BackgroundDepression and anxiety were common psychiatric morbidity among breast cancer patient. This study aims to study the level of depression, anxiety, QoL and PSS among Malaysian breast cancer women over a period of 12 months and their associations at baseline, 6 and 12 months.MethodsIt is a 12-months prospective cohort study. Two hundred and twenty one female patients were included into the study. They were assessed at the time of diagnosis, 6 months and 12 month using Hospital Anxiety and Depression Scale (HADS), Quality-of-Life Questionnaire (QLQ–C30), Version 3.0 and Multidimensional Scale of Perceived Social Support (MSPSS). Relevant socio-clinical characteristic information was collected.ResultsThe HADS anxiety and depression subscales scores of the subjects were relatively low. The level of anxiety reduced significantly at 6 and 12 months (baseline – 6 months, P = 0.002; baseline – 12 months, P < 0.001). There were no changes in the level of depression over the study period. The global status of QoL and MSPSS scores were relatively high. There was positively correlation between the global status of QoL and MSPSS for the study subjects (Spearman's rho = 0.31–0.36). Global status of QoL and MSPSS scores were negatively correlated with anxiety and depression.ConclusionMalaysian breast cancer women had relatively better QoL with lower level of anxiety and depression. Perceived social support was important associated factor for better QoL with low level of psychological distress. It reflected the importance of enhancing and maintaining the social support system for breast cancer patients.Disclosure of interestThe authors have not supplied their declaration of competing interest.


2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Natalja Fatkulina ◽  
Vaiva Hendrixson ◽  
Alona Rauckiene-Michealsson ◽  
Justina Kievisiene ◽  
Arturas Razbadauskas ◽  
...  

Aim. In this paper, we systematically review the evidence looking at the effect of dance/movement therapy (DMT) and mental health outcomes and quality of life in breast cancer patients. Method. The literature search was done with the databases PubMed (MEDLINE), EBSCO, and Cochrane Central by using the following search words: “dancing/dance/movement therapy,” “breast cancer/neoplasms/carcinoma/tumour” or “mammary cancer,” “mental health,” and “quality of life.” Ninety-four articles were found. Only empirical interventional studies (N = 6) were selected for the review: randomised controlled trials (RCT) (n = 5) and non-RCT (n = 1). PRISMA guidelines were used. Results. Data from 6 studies including 385 participants who had been diagnosed with breast cancer, were of an average age of 55.7 years, and had participated in DMT programmes for 3–24 weeks were analysed. In each study, the main outcomes that were measured were quality of life, physical activity, stress, and emotional and social well-being. Different questionnaires were used for the evaluation of outcomes. The mental health of the participants who received DMT intervention improved: they reported a better quality of life and decreased stress, symptoms, and fatigue. Conclusion. We found only six studies for review, and some had a small number of participants. However, our findings indicate that DMT could be successfully used as a complimentary therapy in addition to standard cancer treatment for improving the quality of life and mental health of women who have been diagnosed with breast cancer. More research is needed to evaluate the complexity of the impact of complimentary therapies. It is possible that DMT could be more effective if used with other therapies.


2016 ◽  
Vol 34 (7_suppl) ◽  
pp. 175-175
Author(s):  
Sarah T. Hawley ◽  
Nancy K. Janz ◽  
Reshma Jagsi ◽  
Kent A. Griffith ◽  
Christopher Ryan Friese ◽  
...  

175 Background: Many breast cancer patients overestimate their risk of distant recurrence after treatment. We explored risk perception in a large, diverse population of breast cancer patients with favorable prognosis and assessed associations between overestimation and quality of life (QoL). Methods: As part of the iCanCare Study, we surveyed a weighted random sample of newly diagnosed patients with early-stage breast cancer treated in 2013-14, identified through the population-based SEER registries of Los Angeles & Georgia about 3 months after surgical treatment (N = 2632, RR = 70%). Actual 10-year risk of distant recurrence after treatment was determined for women with DCIS (N = 502), and with low risk invasive (LRI: N = 520, Stg 1A, ER+HER2-, Gr 1-2). Women reported perceptions of their risk numerically between 0 – 100%, with values > 10% for DCIS and > 20% for LRI considered substantial overestimates. We assessed which patient and treatment factors were correlated with overestimation and report the bivariable associations between overestimation and the QoL measures of worry, distress, & PROMIS physical and mental health. Results: One third (36%) of DCIS and 25% of women with LRI breast cancer substantially overestimated their risk of distant recurrence. Overestimation of risk was significantly associated with lower education (p = 0.02), and marginally with lower acculturation (p = 0.08). DCIS patients were more likely to overestimate risk of distant recurrence than LRI patients (OR = 2.0, 95% CI: 1.4-2.7). Women who overestimated risk in both groups reported more worry about recurrence; 49% vs. 16% DCIS, p < 0.001 and 54% vs. 24% LRI, p < 0.001. These women more often had higher distress (0-10 scores, mean of 3.5 vs. 2.5 DCIS p < 0.001, and 3.9 vs. 2.2 for LRI, p < 0.0001) and had poor PROMIS physical (21% vs. 14% DCIS, p < 0.001; 34% vs. 16% LRI, p < 0.001) and mental health (13% vs. 11% DCIS, not significant; 21% vs. 7% LRI, p < 0.001) scores. Conclusions: Marked overestimation of risk after treatment was common, particularly among women with very low risk (DCIS). The strong association between risk overestimates and lower QoL suggests the need to address women’s perception of risk of distant recurrence after treatment of breast cancer. Funding: P01CA163233


Sign in / Sign up

Export Citation Format

Share Document